Identifying the genotype behind the phenotype: a role model found in VKORC1 and its association with warfarin dosing
- PMID: 17465713
- PMCID: PMC3112050
- DOI: 10.2217/14622416.8.5.487
Identifying the genotype behind the phenotype: a role model found in VKORC1 and its association with warfarin dosing
Abstract
Genotype-phenotype studies in pharmacogenomics promise to identify the genetic factors that contribute substantially to variation in individual drug response. While most genetic association studies have failed to deliver this promise, several recent examples serve as a reminder that these associations do exist and can be identified when investigated using well-designed studies. Here, we describe the path taken to identify the association between common vitamin K epoxide reductase complex subunit 1 genetic variation and warfarin dosing in patients. We also describe the key elements that led the way, such as definition of the phenotype, confirmation of a genetic component, determination of biological plausibility and selection of genetic polymorphisms. We also describe several avenues that are yet to be explored for the specific vitamin K epoxide reductase complex subunit 1 warfarin example that can also be generalized as future directions for many genetic association studies in pharmacogenomics. These future avenues will be best explored using diverse approaches encompassing clinical, statistical and genomic methods currently being developed for genotype-phenotype studies in human populations.
Figures

Similar articles
-
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.Clin Pharmacol Ther. 2011 Oct;90(4):625-9. doi: 10.1038/clpt.2011.185. Epub 2011 Sep 7. Clin Pharmacol Ther. 2011. PMID: 21900891 Free PMC article.
-
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.J Thromb Thrombolysis. 2006 Dec;22(3):191-7. doi: 10.1007/s11239-006-9030-7. J Thromb Thrombolysis. 2006. PMID: 17111199
-
Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.Pharmacogenomics. 2008 Feb;9(2):169-78. doi: 10.2217/14622416.9.2.169. Pharmacogenomics. 2008. PMID: 18370846
-
[Possible application of pharmacogenomics to warfarin therapy].Rinsho Byori. 2011 Jun;59(6):594-7. Rinsho Byori. 2011. PMID: 21815482 Review. Japanese.
-
Prediction of warfarin dose: why, when and how?Pharmacogenomics. 2012 Mar;13(4):429-40. doi: 10.2217/pgs.11.184. Pharmacogenomics. 2012. PMID: 22379999 Review.
Cited by
-
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.Oncotarget. 2016 Aug 16;7(33):54028-54050. doi: 10.18632/oncotarget.9927. Oncotarget. 2016. PMID: 27304055 Free PMC article. Review.
-
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose.Blood. 2008 Aug 15;112(4):1022-7. doi: 10.1182/blood-2008-01-134247. Epub 2008 Jun 5. Blood. 2008. PMID: 18535201 Free PMC article.
-
CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.Pharmacogenomics. 2009 Aug;10(8):1243-55. doi: 10.2217/pgs.09.71. Pharmacogenomics. 2009. PMID: 19663669 Free PMC article.
-
Measures of exposure impact genetic association studies: an example in vitamin K levels and VKORC1.Pac Symp Biocomput. 2015:161-70. Pac Symp Biocomput. 2015. PMID: 25592578 Free PMC article.
-
Bridging the Gaps in Personalized Medicine Value Assessment: A Review of the Need for Outcome Metrics across Stakeholders and Scientific Disciplines.Public Health Genomics. 2019;22(1-2):16-24. doi: 10.1159/000501974. Epub 2019 Aug 27. Public Health Genomics. 2019. PMID: 31454805 Free PMC article. Review.
References
-
- Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature. 1953;17:737–738. - PubMed
-
- Venter JC, Adams MD, Myers EW, Li PW, Mural RJ. The sequence of the human genome. Science. 2001;291:1304. - PubMed
-
- Initial sequencing and analysis of the human genome. Nature. 2001;409:806. - PubMed
-
- Motulsky A. Drug reactions, enzymes and biochemical genetics. JAMA. 1957;165:835–837. - PubMed
-
- Fan JB, Chee MS, Gunderson KL. Highly parallel genomic assays. Nat Rev Genet. 2006;7:632–644. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials